Today: 19 May 2026
Browse Category

ASX:EVN 12 December 2025 - 1 February 2026

Evolution Mining share price slides 6% on gold pullback — what to watch before Monday’s ASX open

Evolution Mining share price slides 6% on gold pullback — what to watch before Monday’s ASX open

Evolution Mining shares fell 6.4% to A$14.71 Friday as gold prices dropped 4.7% to $5,143.40 an ounce and mining stocks slid across the ASX. The company will release its half-year results and hold a conference call on Feb. 11. Evolution reaffirmed full-year gold and copper guidance. Investors await earnings season and the Reserve Bank of Australia’s policy decision next week.
31 January 2026
Evolution Mining share price jumps 5% as gold nears $5,000 — what to watch when the ASX reopens

Evolution Mining share price jumps 5% as gold nears $5,000 — what to watch when the ASX reopens

Evolution Mining shares closed at A$14.86 Friday, up 5.3%, with 7.43 million shares traded as gold prices neared record highs. The ASX will remain shut until Tuesday for the Australia Day holiday. Evolution’s quarterly report showed record mine cash flow but flagged a rain-related halt at Ernest Henry, which may trim copper and gold output. Investors await half-year results on Feb. 11.
Northern Star share price: NST jumps 5% as gold hits records, but costs and broker nerves linger

Northern Star share price: NST jumps 5% as gold hits records, but costs and broker nerves linger

Northern Star Resources rose 5.4% to A$27.60 Friday as gold prices neared record highs, despite the company raising its FY26 cost forecast to A$2,600–A$2,800 per ounce. UBS downgraded the stock to Neutral on Jan. 22. The miner reported December quarter gold sales of 348,061 ounces at an AISC of A$2,937. Half-year results are due Feb. 12.
Evolution Mining share price jumps 5% as EVN rides gold rally and record cash flow — what to watch next

Evolution Mining share price jumps 5% as EVN rides gold rally and record cash flow — what to watch next

Evolution Mining shares surged 5.3% Friday to A$14.86 after reporting record December-quarter cash flow of A$1.1 billion and reduced costs. The company produced 191,000 ounces of gold and 18,000 tonnes of copper, holding A$967 million in cash at quarter-end. Ernest Henry mine is set to restart processing by late January after rain-related shutdowns. The ASX will remain closed Monday for Australia Day.
23 January 2026
Northern Star shares rise into ASX close as gold cools — what to watch before Jan 22 update

Northern Star shares rise into ASX close as gold cools — what to watch before Jan 22 update

Northern Star Resources shares rose 1.16% to close at A$27.04 Thursday, ahead of its December-quarter update due Jan. 22. The company recently cut its FY26 production forecast to 1.6–1.7 million ounces and plans to release updated cost guidance. Gold prices dipped after hitting record highs the previous day. The ASX pressed Northern Star for details following its production downgrade.
Evolution Mining stock ends higher as gold hits a one-week high; EVN investors eye Jan 21 update

Evolution Mining stock ends higher as gold hits a one-week high; EVN investors eye Jan 21 update

Evolution Mining shares closed up 0.2% at A$12.82 Tuesday as gold prices rose, trading just below a 52-week high of A$13.30. The company will release its December-quarter report and hold a call on Jan. 21. Investors are watching U.S. jobs data Friday and Evolution’s production update for signals on margins and costs. The ASX 200 ended down 0.5%, while basic materials gained 1.5%.
6 January 2026
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 25.12.2025

Gold surged about 70% in 2025, with silver up 140%, driving gains for producers and explorers on the ASX. Evolution Mining rose 165%, Newmont 150%, and Lynas 95%. NVIDIA drew attention with a Groq licensing deal and possible H200 chip exports to China by February, pending approval. U.S. export licensing remains a risk for NVIDIA’s revenue.
25 December 2025
Evolution Mining Limited (ASX: EVN) Stock Surges With Record Gold Prices: EVN Share Price, Forecasts, Analyst Targets and What to Watch Next

Evolution Mining Limited (ASX: EVN) Stock Surges With Record Gold Prices: EVN Share Price, Forecasts, Analyst Targets and What to Watch Next

Evolution Mining shares closed at A$13.04 on Dec. 23, 2025, up 0.15%, after gold hit a record near US$4,500 an ounce. The stock’s 52-week range widened to A$4.79–A$13.09, with EVN up about 170% in 2025. Gold’s surge, driven by safe-haven demand and rate cut expectations, fueled gains across Australian gold equities.
Evolution Mining Limited (ASX: EVN) Stock: Latest News, FY26 Outlook, and Analyst Forecasts as Gold Prices Stay Elevated

Evolution Mining Limited (ASX: EVN) Stock: Latest News, FY26 Outlook, and Analyst Forecasts as Gold Prices Stay Elevated

Evolution Mining closed at A$12.62 on 19 December, near its 52-week high, with a market value of about A$25.6 billion after a 141% one-year gain. The company remains highly exposed to gold prices, which hovered near US$4,340/oz this week, with limited hedging left for FY26. Copper prices and supply outlooks are also drawing investor focus.
21 December 2025
Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining closed at A$12.62 on December 19, near its 52-week high of A$12.81, with a market cap around A$25.6 billion and P/E near 27. The company awarded a five-year underground mining contract at Cowal to Redpath, targeting full production by July 2026. Cowal also received full compliance under the International Cyanide Management Code.
20 December 2025
Evolution Mining (ASX: EVN) Share Price Surges on Gold’s $4,280 Rally — Latest News, Analyst Forecasts, and Week-Ahead Outlook (Updated 14 Dec 2025)

Evolution Mining (ASX: EVN) Share Price Surges on Gold’s $4,280 Rally — Latest News, Analyst Forecasts, and Week-Ahead Outlook (Updated 14 Dec 2025)

Evolution Mining shares closed at A$12.76 on Friday, up 8.6% for the week, as gold prices surged and safe-haven demand lifted mining stocks. The stock touched a 52-week high of A$12.81 and is up about 154% year-to-date. EVN confirmed its December quarter update and investor call for January. Market cap stands near A$24.9 billion.
Evolution Mining Limited (ASX:EVN) Stock After the Bell 12.12.2025: EVN Closes at A$12.76 Near a Fresh High — What to Know Before the Next Market Open

Evolution Mining Limited (ASX:EVN) Stock After the Bell 12.12.2025: EVN Closes at A$12.76 Near a Fresh High — What to Know Before the Next Market Open

Evolution Mining closed at A$12.76 on Friday, hitting a new 2025 high after reaching A$12.81 intraday. Shares have surged about 164% this year, up from A$4.83 in January. The S&P/ASX 200 rose 1.23%, while the Gold Sub-Index jumped 4.5%. Trading volume for EVN reached 6,015,424 shares.
Evolution Mining (ASX: EVN) Share Price Near Record High: Today’s News, Forecasts and Analyst Outlook (Dec 12, 2025)

Evolution Mining (ASX: EVN) Share Price Near Record High: Today’s News, Forecasts and Analyst Outlook (Dec 12, 2025)

Evolution Mining (ASX: EVN) traded near A$12.7 on December 12, close to its 52-week high after gaining over 150% year-to-date. The company announced its December quarter results will be released before market open on January 21, 2026, with a conference call to follow. Strong gold prices and sector momentum have driven recent gains.
12 December 2025

Stock Market Today

  • LeMaitre Q1 Performance Trails Surgical Equipment Sector Leaders
    May 19, 2026, 5:33 AM EDT. LeMaitre (NASDAQ:LMAT) reported Q1 revenue of $66.55 million, up 11.2% year-on-year but missed the mark relative to analyst estimates and offered weaker full-year guidance than peers. Despite beating earnings per share (EPS) estimates for the upcoming quarter, LMAT's stock fell 10%, trading at $100.83. In contrast, sector leader Intuitive Surgical (NASDAQ:ISRG) delivered a 23% revenue increase to $2.77 billion, surpassing expectations by 5.8%, driven by its robotic-assisted surgical systems business. The surgical equipment and consumables sector as a whole beat revenue estimates by 2.7% for Q1, with stocks rising an average of 6.4%. Industry growth is underpinned by aging populations and expanding use of AI and robotics, although challenges remain around R&D costs, regulatory compliance, pricing pressures, and potential supply chain issues.

Latest articles

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Go toTop